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Plain English summary
Cochrane is the largest international producer of systematic reviews of clinical trial
evidence. We looked for published evidence that reports where consumers (patients
and the public) have been involved in Cochrane systematic reviews, and also in
reviews published by other organisations.
We found 36 studies that reported about consumer involvement either in individual
systematic reviews, or in other organisations. The studies showed that consumers
were involved in reviews in a range of different ways: coordinating and producing
reviews, making reviews more accessible, and spreading the results of reviews
(“knowledge transfer”). The most common role was commenting on reviews (“peer
reviewing”). Consumers also had other general roles, for example in educating
people about evidence or helping other consumers. There were some interesting
examples of new ways of involving consumers. The studies showed that most
consumers came from rich and English speaking countries. There was little evidence
about how consumer involvement had changed the reviews (“impact”). The studies
found that consumer involvement needed to be properly supported.
In future we believe that more research should be done to understand what kind of
consumer involvement has the best impact; that more review authors should report
how consumers have been involved; and that consumers who help with reviews
should come from more varied backgrounds.
Abstract:
Background Cochrane is the largest international producer of systematic reviews,
and is committed to consumer involvement in the production and dissemination of
its reviews. The review aims to systematically scope the evidence base for consumer
involvement in organisations which commission, undertake or support systematic
reviews; with an emphasis on Cochrane.
Methods In June 2015 we searched six databases and other sources for studies of
consumer involvement in organisations which commission, undertake or support
systematic reviews, or in individual systematic review processes. All types of reports
and evaluations were eligible. Included studies were combined in a narrative
synthesis structured by the level of evaluation and the type of involvement.
(Continued on next page)
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Results We identified 36 relevant studies. Eleven of these were evaluations at the
level of a whole organisation; seven of these studied consumer involvement in
Cochrane. Ten studies examined individual Cochrane review groups. Twelve studies
reported on individual reviews; only two of these were Cochrane reviews. Finally,
three studies were themselves syntheses of other studies. The included studies
reported varying levels of consumer involvement across a wide range of activities
related to review design and conduct. These included activities such as priority
setting and outcome definition as well as review-specific roles such as acting as peer
referees and producing plain language summaries. The level of satisfaction and
awareness of impact was generally higher in studies focused on individual Cochrane
review groups than in the organisation-wide studies.
Conclusions There was evidence of highly variable levels and types of consumer
involvement within and beyond Cochrane, but limited evidence for what makes the
most effective methods and levels of involving consumers in review production.
Where evidence of impact was found at the level of individual reviews and review
groups it underlined the need for properly resourced and supported processes in
order to derive the greatest benefit from the lived experiences of consumers who are
willing to be involved. Where reviews do involve consumers, their contribution to the
final result could be more clearly identified. More rigorous evaluations are needed to
determine the best approach to achieving this.
Trial registration Not applicable.
Keywords: Consumer, Involvement, Systematic Reviews, Organisations, Impact
Background
There is increasing acceptance of the need to involve patients and members of the pub-
lic (consumers) in all types of health research. This includes systematic reviews, which
help shape health policy and practice. There is existing research on the impact of in-
volving consumers in systematic reviews both at the level of the individual review [1]
and at an organisational level [2].
Cochrane is a global independent network of researchers, professionals, patients,
carers, and people interested in health and is the largest international producer of sys-
tematic reviews involving 37,000 contributors from more than 130 countries. Cochrane
reviews are overseen by Cochrane Review Groups (CRGs) of which there are presently
53, organised by health condition or setting. Cochrane is committed to involving con-
sumers in the production and dissemination of systematic reviews. Healthcare consumers
who use Cochrane evidence are generally patients, carers and family members, or people
interested in remaining healthy who are seeking information about a health condition or
treatment for personal use. Cochrane’s Consumer Network (CCNet) comprises over 1500
healthcare consumers and others, including members of patient advocacy groups and
people with an interest in the organization of healthcare, such as practitioners who sup-
port patient participation in health research.
This systematic scoping review aims to document and analyse the most recent evi-
dence on involvement in systematic reviews at multiple levels of Cochrane and to
identify models used in other organisations which commission or produce systematic
reviews. This forms part of a broader review of the structures and functions of
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Cochrane that includes consumer involvement. Where possible we sought to identify
the impacts of particular types of consumer involvement on outputs and processes.
Research on consumer involvement in individual systematic reviews was also gath-
ered and used to allow comparisons between involvement in individual and organisa-
tional level reviews.
Methods
Objective
To conduct a systematic scoping exercise to evaluate the evidence base on consumer
involvement in organisations which commission, undertake or support systematic reviews;
with an emphasis on Cochrane.
Inclusion criteria
Any study which evaluated or reported on consumer involvement in an organisation which
commissions, undertakes or otherwise supports systematic reviews, or which reported on
consumer involvement in an individual systematic review process (or processes) was
eligible for inclusion.
Exclusion criteria
We excluded studies which reported on consumer involvement in research which did not
explicitly include systematic reviews. This included studies of priority setting exercises
where this was not related to the undertaking of systematic reviews.
Search methods
We searched the following databases and other electronic sources in June 2015:
 CINAHL Plus
 MEDLINE In-Process & Other Non-Indexed Citations and MEDLINE
 Embase
 Cochrane Methodology Register (CMR)
 HMIC Health Management Information Consortium
 ProQuest Dissertations & Theses: UK & Ireland
The searches were date-limited to records from 1990 onwards and were designed by
an information specialist. Full search strategies are provided in the Additional file 1:
Table S1, S2, S3. They included search terms related to Cochrane.
Records retrieved were independently assessed by two researchers. Potentially rele-
vant records were obtained as full texts. Full text assessment was also carried out by
two independent researchers. One researcher also searched the abstracts of Cochrane
Colloquia. We contacted authors/experts in the field in order to identify full texts of
potentially relevant studies identified in this way but did not explicitly contact the con-
sumer network. References from all identified studies and other relevant summaries
and bibliographies were also checked to identify additional studies.
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Data extraction and Synthesis
One researcher extracted data into structured tables. Data were extracted on the
following:
 Bibliographic information
 Country where data were collected
 Organisation, group or topic evaluated
 Methodological or geographical focus
 Study methodology
 Individuals and activities surveyed or evaluated
 Consumer characteristics
 Results of consumer involvement
 Results of evaluation
 Impact of consumer involvement
Studies were grouped by the level at which the evaluation was performed (organisa-
tional, individual Cochrane Review Group (CRG), or individual systematic review(s)).
Organisational studies were further grouped by whether the evaluation was focused on
Cochrane, another organisation or on multiple organisations. Studies of individual
CRGs were grouped by the CRG evaluated. Syntheses of studies were not extracted as
individual studies but were used to ensure that all individual studies were identified
and included.
A narrative synthesis was produced, structured by the study groupings identified.
Themes of types of involvement and impacts were identified, as were perceived barriers
to involvement. Emphasis was given to those studies which evaluated the impacts of
consumer involvement. Consumers’ perceptions of their involvement were also
highlighted.
Results
We identified a total of 4299 records from the database searches. Sixty of these were
identified as potentially relevant and ordered as full texts. Searching Cochrane ab-
stracts, contacting authors and experts in the field and reference checking identified an
additional 10 records. 42 records referred to 36 relevant studies and were included, 26
were excluded and 2 records have proved unobtainable (see Additional file 2: Appendix 1).
A total of 36 studies reported in 42 publications were included (Fig. 1).
Types of included studies
We identified four types of reports (Table 1):
1) Surveys and other evaluations of consumer involvement at an organisational level in
Cochrane or another organisation
2) Case reports, surveys or other evaluations of consumer involvement in a single CRG
3) Case examples of consumer involvement in individual systematic reviews (Cochrane
and non-Cochrane)
4) Syntheses or summaries of consumer involvement in individual systematic reviews
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Organisational level evaluations (Additional file 1: Table S1)
Seven organisational level evaluations focused on the Cochrane collaboration [3–9];
three focused on other organisations [10–12] while one evaluated multiple organisa-
tions including Cochrane and some individual CRGs [13]. A final study looked at the
views of consumers from external organisations on Cochrane reviews from the perspec-
tive of the German HTA (IQWiG) [14].
Reports from individual CRGs (Additional file 1: Table S2)
The 10 case studies identified related to only four CRGs. These were the Pregnancy
and Childbirth Group (4 studies), [15–17] the Skin Group (2 studies), [18, 19] the
Musculoskeletal Group (3 studies), [20–22] and the Haematological Malignancies
Fig. 1 Flow diagram of identified records and included studies
Table 1 summary of identified studies
Number of studies Organisational level
evaluations
CRG case reports Individual reviews Syntheses/summaries
Total 11 10 12 3
Cochrane 7 NA 2 NA
Non-Cochrane 4 NA 10 NA
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Group (1 study) [23]. Study dates ranged from 1998 to 2013. Groups were based in
the UK, USA, Canada and Germany. One of these studies represented the only com-
parative design identified – this was a historical comparison of two methods of in-
volvement [15].
Individual review case studies (Additional file 1: Table S3)
We identified a total of 12 case studies of consumer involvement in 13 individual system-
atic reviews [24–36]. Only two of the case examples were Cochrane reviews [27, 29]. We
also identified three syntheses or summaries of case examples [1, 2, 37]. The great major-
ity of the case studies included in these research syntheses were independently identified
by our search strategy. We therefore took the decision not to extract or further analyse
the syntheses but to include any remaining studies as case examples. This represented a
protocol deviation but we believe that in the context of a scoping review, it maximised the
available information.
Differences between the study types identified
Studies of involvement at different levels took different approaches to the types of data
sought and the ways in which both types of involvement and impacts were defined and
characterised. This was partly a consequence of the breadth of possible involvement
surveyed but also reflected the particular focus of study authors.
Organisational level studies were more likely to report hard data on numbers of con-
sumers involved at specific stages of the review production process, whilst studies of indi-
vidual groups or reviews, perhaps unsurprisingly, were more likely to report qualitative
data on the views of consumers, reviewers and other stakeholders about their level of
involvement and its perceived impacts. Most likely to report a concrete change in the
finished research were studies of individual reviews, perhaps because the process was
easier to trace for a single piece of research.
Reports from individual review groups or of involvement in individual reviews were
also extremely likely to be positive about involvement and impact from both the consumer
and the researcher/organisational perspective. This is perhaps also unsurprising, and is
probably indicative of the fact that these publications are likely to derive from groups of
researchers and consumers which have a high level of commitment to involvement.
The suggestion that this published/reported literature may be self-selecting is supported
by the more ambivalent levels of confidence in impact identified by Cochrane-wide sur-
veys which included almost all the review groups.
Types of involvement
Most of the studies had a general focus. Earlier studies tended to address whether con-
sumers were involved in any capacity, and often to report this as a perceived impact in
itself. However, later studies reported in more detail on the types and depth of involve-
ment. The types of involvement which were documented could be broken down into four
main categories: formal roles in review production and co-ordination, roles in review pro-
duction, roles in increasing the accessibility of review, and roles in knowledge transfer. In-
dividual contribution types are shown in Table 2. This also lists the perceived impacts of
consumer involvement in terms of the final reviews produced. Broader impacts are also
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Table 2 Consumer roles and identified impacts on outputs
Consumer roles (defined by role
in review or organisation)
Consumer activities in review
process
Consumer roles in increasing accessibility
of reviews
Consumer roles in knowledge transfer Impacts identified
Membership of editorial teams Hand searching Plain language summary preparation Coordination of workshops, seminars
and presentations on CRG activities
during consumer organisation conferences
Use of consumer-oriented/more relevant
outcomes
Consumer coordination Obtaining information Removal of unfriendly jargon from
synopses & other documentation
Participation in working groups Changes in language – greater
accessibility
Review authorship Peer review of protocols and
reviews
Collaboration with external consumer
organisations to publish synopses
Dissemination Informing of/altering methodology
Peer reviewer Priority setting Translation Raising awareness of evidence-based
healthcare
Adding “depth” to the review
Advisory group member Incorporation of patient-derived
outcomes
Publication of synopses/other CRG
documentation in languages other
than English
Identifying the needs for non-professional
consumer involvement
Better prioritisation of review topics
Stakeholder (various stages) Input into relevance of review
question
Recruiting others Increased relevance of review
Member of the public Peer mentoring Increased timeliness
Training other consumers Reduction in bias
Input into funding bids Broader and more inclusive literature
searches
Developing partnerships with other relevant
organisations
More clearly defined research questions
Contributions to newsletter Identification of additional included
studies
Preparing decision aids for patients Increased depth, relevance and
usefulness of review
Indirect benefits to all involved
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discussed later. A minority of studies focused on a specific activity such as outcome iden-
tification, priority setting or peer reviewing, either across organisations or within a Review
Group. All contributions and roles contained in the table represent reported involvement;
roles which are desirable but not reported as undertaken are not included.
Both of the individual Cochrane reviews reported high levels of consumer involve-
ment throughout the review processes [27, 29]; levels and types of involvement in the
non-Cochrane reviews were more variable. Many were conducted by or in partnership
with the UK EPPi Centre or the Social Care Institute for Excellence (SCIE) and covered
public health topics. The level of reported involvement varies greatly: from a consumer
acting as a principal investigator; through co-authorship; heavily involved advisory
groups; to a single conference with users supported by some additional contact. These
case examples have almost all been included in at least one published synthesis (Boote
2011, Boote 2012, Carr 2007) and are not the primary focus of this work [1, 2, 37].
They are not, therefore analysed in detail but are detailed for the interested reader in
Additional file 1: Table S3.
Levels of involvement
Organisational and review process activities
Organisational roles undertaken by consumers in Cochrane included as member of edi-
torial teams, consumer co-ordinator, review author and peer reviewer. By far the most
common of these was peer reviewer of protocols and reviews [6]. Reflecting this, peer
review was one of the key activities in the review process, although it occurs late on in
the review production. Activities which occur before a review begins, such as priority
setting, question setting, or outcome determination were much less frequently re-
ported, although increasingly regarded as important. Other activities occurring earlier
in the review process included hand searching and “obtaining information”. It was not-
able that the Skin Group (one of the four CRGs with published case studies) reported
that there were high levels of co-authorship among consumers, which may be reflective
of their generally high levels of consumer activity and satisfaction [19].
In non-Cochrane organisations consumers were also members of advisory boards [13] or
were identified as stakeholders with roles throughout and across the review process [10].
Roles in increasing accessibility
A larger number of roles for consumers which we identified could be classed as in-
creasing accessibility of reviews or knowledge transfer, although these inevitably overlap
to some degree with review processes and with each other. Activities included review-
ing and preparation of plain language summaries, and editing of language in both these
and other synopses. They also included translation activities – both translation of full
reviews and preparation of synopses in languages other than English. Collaboration
with external consumer organisations to publish synopses can also be included with
this type of activity.
Review promotion activities and knowledge transfer
Knowledge transfer was identified as the largest class of consumer-related activity. Con-
sumers were documented as being involved across a very wide range of activities which
promoted the role of reviews and research more generally, rather than involvement
with a single review or set of reviews (Table 2). This included participation in working
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groups and partnership development work, conference-based activities, educational,
outreach or awareness raising for reviews and evidence-based healthcare more gener-
ally. In some cases this also included preparing decision aids for patients. Consumers
were also documented as writing for other media and, crucially, providing different
types of support and training for fellow consumers and facilitating their recruitment. In
some cases contributions to funding applications were documented. These activities
were particularly documented in the very active consumer involvement of the Canadian
Health Technology Assessment (HTA) and the Cochrane Musculoskeletal Group
[10, 20–22].
Levels of consumer involvement: Cochrane
Some of the Cochrane-wide evaluations used surveys of CRGs or audits of data
returned by CRGs for other purposes, [7, 8] while others directly surveyed or inter-
viewed consumers and people in other key roles in CRGs [3–6]. Earlier reports focused
on whether consumers were involved in any capacity, finding that the majority of CRGs
(25/33; 79% response rate) had consumer involvement and that many of the others
were planning to introduce involvement [4]. Only 6 CRGs described themselves as un-
convinced about the merits of consumer involvement. These early studies also reported
a range of roles for consumers within CRGs [3]. However, as late as 2009 a substantial
minority of CRGs stated that they did not involve consumers (8/47 responses; 90% re-
sponse rate) or did not respond to the question (4/52) [6].
Unsurprisingly all the case studies of CRGs we identified showed high or increasing
levels of involvement because they were produced by self-selecting review groups.
An interesting case study of methods to increase involvement was conducted by
Skoetz (2005) who reported on a pilot project to establish a consumer network for
the Haematological Malignancies CRG based in Germany [23]. This was the only
case study conducted in a non-English speaking country. This project involved the
provision of workshops covering topics such as research methods followed by ongoing en-
gagement. This increased participation in both this CRG and in two other oncology CRGs;
positive consumer reviews also increased with responses indicating that people felt patient
concerns were very influential in the review process. The CRG notes that running a focus
group on a review produced better and more comprehensive feedback than “just sending
out forms”.
Level of consumer involvement: Beyond Cochrane
We identified one relatively recent multi-organisation study. Kreis (2013) conducted
in-depth interviews with key informants, combined with reviews of organisational web-
sites across 17 US-based and international organisations involved in the production of
systematic reviews; Cochrane and the Musculoskeletal and Pregnancy and Childbirth
Groups were included [13]. Seven organisations reported that they routinely involved
consumers in reviews. These were the Campbell and Cochrane collaborations, the two
CRGs, the Agency for Healthcare Research and Quality (AHRQ) and the Oregon and
Johns Hopkins Evidence-based Practice Centres (EPC). Other organisations reported
occasional involvement in reviews or regular involvement in other aspects of their
operations.
Types of involvement included priority setting (extensive involvement being reported
by AHRQ and its EPCs). Other involvement included suggestion of topics and advice
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on key review questions. Consumers sat on advisory groups, commented on review and
protocol drafts and in some cases acted as review co-authors.
Evaluations from individual organisations other than Cochrane were conducted by a
Canadian HTA-style organisation (Keown 2008), the US Drug Effectiveness Review
Project (McDonagh 2006) and the UK MRC Clinical Trials Unit (Vale 2012a) (which
included all studies of which a minority were systematic reviews) [10–12]. Both Keown
and McDonagh, using very different models of engagement, identified significant and
substantive changes to the final reviews as a consequence of public involvement.
An audit of involvement by 80 stakeholders over four years and 22 reviews by the
Canadian HTA organisation documented five stages of possible involvement from topic
consultation to determine the research question through to drafting, production and
dissemination of the final report [10].
A very different model of consumer involvement was evaluated by McDonagh (2006)
[11]. All 26 drug class reviews produced by the US Drug Effectiveness Review Project
(DERP) were made publicly available for comment through the organisational website.
An organisation-wide survey of consumer involvement in all types of research was
carried out by the UK Medical Research Council (MRC) clinical trials unit [12]. Sys-
tematic reviews made up only a minority (n = 23, 17%) of studies. The number with
consumer involvement was not reported but two examples of useful consumer involve-
ment were highlighted. These are included in the individual systematic review case
examples.
Evaluation of specific consumer roles
Cochrane organisational evaluations which focused on particular aspects of involvement
looked at involvement of consumers in incorporating patient-derived outcomes into the
review processes [4], the use of consumer refereeing for all protocols and reviews [8]; and
levels and types of involvement in priority setting [5]. The role of the CCNet was explored
by one study as part of a more general evaluation [7]. One study looked specifically at
consumer involvement in a non-Western country, examining the establishment of a
multi-disciplinary group of consumers in China [3, 8].
Specific roles: patient-defined outcomes
Identification of relevant outcomes was one of the key activities identified by both
Cochrane-wide and CRG-specific case studies. An early study by Kelson (1999) identi-
fied CRGs’ interest in patient defined outcomes [4]. Thirty-three of 42 CRGs returned
completed questionnaires. Of these just over half (58%) had discussed patient-defined
outcomes while around a third (36%) had liaised with consumers or consumer organi-
sations about them and a further two had identified organisations to contact.
Identification of relevant outcomes was identified by Ghersi (2002) as an important
impact of consumer involvement in the Breast Cancer Group and by Kelson (1999)
across CRGs [3, 4]. It was not specifically identified by other general surveys as being a
key contribution, but may still have been included in the high levels of comments and
contributions to protocols and reviews. Case studies from the Pregnancy and Childbirth
and Musculoskeletal CRGs, while not specifically focused on this issue, identified sug-
gestions of relevant outcomes as one of the main contributions of consumers to reviews
[15–17, 20, 38].
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Specific roles: priority setting
Nasser (2013) identified limited consumer involvement in formal priority setting across the
CRGs and other Cochrane groupings. 29/52 groups (78% response rate) had a process to in-
form prioritisation. Stakeholder involvement was reported in all except two of those reporting
a process; not all of these involved consumers. Fourteen groups appeared to involve con-
sumers in some way in the process; only one of these involved the public and the press. Only
one formal appeal process for the challenging of prioritisation decisions was identified [5].
Priority setting was identified (by other papers which did not specifically focus on this
as a discrete topic) as something to which consumers contributed. Five CRGs identified
topic prioritisation as an activity undertaken by consumers in Wale (2010) and it was
identified as a positive impact of involvement by Kelson (1999) [4, 6]. Two of the four
CRGs for which case studies were identified reported priority setting as one of the activ-
ities undertaken by consumers (Pregnancy and Childbirth Group and Musculoskeletal
Group) [16, 17, 20–22].
Bastian (2011) took a novel approach to involvement in priority setting. She used a
web-based survey of employees of the German HTA and members of CCNet and an-
other international email lists [14]. Respondents were asked to evaluate the level of
interest of Cochrane review summary statements which did and did not meet HTA eli-
gibility criteria. Only 8% of the summary statements were rated as significantly interest-
ing; 100% of these were for common conditions and 71% had enough evidence to draw
conclusions. 50% were significantly uninteresting. Reviews that lacked sufficient evi-
dence to draw a conclusion were less likely to be significantly interesting (7% vs. 12%).
These findings could then be used to inform future prioritisation processes, including
for primary research.
Specific roles: refereeing and review readability
Wale (2010) identified a wide range of roles undertaken by consumers (in line with
other evaluations) but the majority of CRGs (38/47) wanted to involve consumers in
order to improve readability of reviews (38/47) and plain language summaries (36/47)
[6]. Commenting on reviews and protocols was also the activity most commonly re-
ported in both 2006 and 2009 surveys of consumers: 54% and 67% of consumers were
engaged in these activities. Plain language summary preparation was much less com-
monly reported (25% in 2006 and 18% in 2009). Of those involving consumers just over
half of groups felt that they were gaining the desired benefits, while 14/35 were unsure.
In line with this, only around half of consumers felt that their involvement made a
positive difference and many found it difficult to assess their impact.
The slightly earlier review of monitoring forms and reports submitted by CRGs
(Zhang 2008) had found that fewer than half (23/51) involved consumers in the refereeing
of all their protocols [8]. Of those reporting that this was not the case (27/51), 14 provided
details stating that they planned to have universal consumer input in the coming years.
Wale 2010 did not report on whether the number of CRGs with universal consumer input
to reviews had increased in line with the importance placed upon it [6].
The organisation-wide emphasis on consumer involvement in peer refereeing was
reflected in the focus of case studies from CRGS. The group with the most evaluations
(four), and the most in-depth evaluations was the Pregnancy and Childbirth group. All
of these focused on consumer involvement in peer-refereeing.
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One of these studies involved a comparison of 2 models of consumer refereeing [15].
This compared one model where a consumer panel was used for the period up to 2007
with a model of peer review as commonly used for other reviews. The consumer panel
model was highly acceptable to both consumers and editors and was discontinued for
cost reasons. The peer referee model was less popular with both groups and was viewed
by editors as producing less consistent, and less relevant feedback. The impact of the
change was regarded as potentially cost-effective but the loss of consumer-led initia-
tives and absence of appropriate input to some reviews were regarded as negatives.
Previous evaluation of consumer input to this group from editors was positive, citing
differences (not further specified) which the consumers made to final reviews. Review
authors were more varied in their views while consumers were all uncertain as to the
impact of their work due to lack of feedback on its quality and input into the final
review (Horey 2005) [38].
Other reports on this group also dated from the period in which the consumer panel
was active [16, 17, 39]. One examined the impact of consumer feedback on a specific
topic-based subset of reviews and identified the specific types of useful feedback [39].
This was the only study which reported the relationship between consumer involvement
and specific changes to reviews which resulted from the involvement. An audit of peer re-
view over the first 2 years of the panel identified similar issues raised [16, 17]. Both studies
identified positive impacts of consumer participation on the review process.
The Cochrane Skin Group published a case study which reported universal peer
refereeing [19]. This group also reported increasing numbers of consumers and activity,
and an almost unanimous view among consumers that their contribution was important
and significant [18, 19].
Across the included studies which reported on peer refereeing, several types of con-
tribution were identified. These addressed the relevance, conduct and accessibility of
reviews. Key contributions included: providing and seeking clear rationales for reviews;
ensuring the use of outcomes that matter to patients including adverse events/adverse
effects of treatments; raising methodological concerns and queries about interpretation
of data; seeking explanation of terms and making suggestions about accessibility, sensitiv-
ity, precision and clarity of language; and practical suggestions e.g. addressing potential
conflicts of interest; amending titles.
Many of the reports identified ways in which the CRG felt that consumer involve-
ment impacted on both reviews and the group more widely. These were not quantified
and no report provided an audit trail for the impact of consumer input on the final re-
view. Reports from three of the CRGs were uniformly positive but did not report spe-
cific examples of impact. Consumers in these groups clearly felt valued, however. Some
in-depth studies on the Pregnancy and Childbirth Group were more equivocal. Whilst
editors stated that input resulted in specific changes to reviews, review authors shared
a range of views about the impact on the reviews, and consumers and consumer co-
ordinators were uncertain about the impact of their contribution (Horey 2005, Gyte
2005) [38, 40]. Exploration of a subset of reviews, which identified positive contribu-
tions, supports the suggestion that this uncertainty may result from a lack of feedback
(Horey 2004) [39].
The view that more investment in obtaining consumer feedback results in more
valuable input was supported by Gyte’s 2011 comparison of two models for consumer
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comments on reviews, [15] and by the pilot approach of Skoetz (2005) who reported
on the benefits of running a focus group to obtain input, although this was not specific to
reviewing [23].
Impacts of consumer involvement
Impacts of consumer involvement were characterised in different ways by the included
studies. Some of these have been discussed in detail in consideration of individual roles
for consumers. The cross-organisational study by Kreis identified only one formal evalu-
ation of consumer involvement and this was the survey by Wale (2010) of Cochrane [6].
Several informal evaluations identified by Kreis’s survey were all positive about impacts
on relevance and usefulness of reviews. Some identified concrete examples of differences
made by consumer involvement; others reported that the benefits were less tangible. In-
direct benefits to all involved parties (organisation, research groups and consumers) were
also commented on.
Tangible beneficial impacts on review relevance and quality were documented by
studies of Canadian and American organisations [10, 11]. In the Canadian HTA
programme, impact assessments by both researchers and stakeholders was positive,
identifying increasing depth, relevance and usefulness of the final review. Stakeholder
involvement early in the review process was identified as resulting in broader and more
inclusive literature searches and more clearly defined research questions. Later involve-
ment was associated with identification of important issues around the clarity of the final
report and the recommendations made. The US DERP noted that all of their reports
underwent some basic editing changes made on the basis of the comments received. In
several cases significant changes were made to methods sections. In many reviews a small
number of additional studies were identified by the public; these were added to the re-
views and constituted changes with the potential to alter the outcome of the review.
Changes in inclusion criteria as a result of comments were rare but in one case they were
broadened to include observational studies.
Most of the case examples of individual reviews were not Cochrane reviews and were
highly variable in their level of involvement. The two Cochrane examples were reviews
of physiotherapy for stroke (Pollock 2015) and of treatments for degenerative ataxias
(Serrano-Aguilar 2009) [27, 28]. Both reported high levels of involvement throughout
the review processes and substantive changes in the review process and the final review
as a consequence of consumer involvement which was integral to the review.
The theme of indirect benefits was noted in the reporting of the CRG case studies,
which highlighted that their teams were strengthened by consumers who were respon-
sible for the inclusion of different perspectives; incorporation of quality improvement
mechanisms; a more open and inclusive process; and more collaborative and stronger
teams. It is notable that many of the activities where highly active CRGs reported con-
sumer involvement – such as peer mentoring and partnership development – may
themselves be characterised as impacts of involvement, in that they demonstrate the
development of a highly skilled and motivated consumer group which is greatly
empowered. In some cases the way in which we define an impact and an involvement
activity should be considered fluid.
General impacts which were identified across studies included: increased relevance
and timeliness; better dissemination including greater accessibility; and a reduction in
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bias. It seems reasonable to suppose that some of these benefits were derived, at least
in part, from the improved processes identified by the impacts on the research groups.
The intangible nature of some of the benefits that were documented may explain
some of the lack of certainty about impact which was documented in many of the stud-
ies, particularly relating to consumers’ views of their involvement in peer refereeing.
Barriers to consumer involvement
CRGs responding to Wale 2010’s survey and who did not have consumer involvement
in their reviews, identified the need for more staff resources and guidance on consumer
involvement as barriers to introducing it; a minority also identified the appropriateness
of reviews for consumers as an issue [6]. Responses in Zhang (2008) identified the (lack
of ) relevance or interest of reviews to consumers, timescales of review groups and
funding for the identification of consumers as barriers to universal consumer review
[8]. Zhang 2004, which was the only study to focus on a non-Western country, identi-
fied a number of barriers to consumer involvement which applied in China [9]. These
included language, information scarcity, cultural differences, education, funding, com-
munication system difficulties and lack of facilities.
These difficulties may be present in other developing countries. Wale (2010) identified
the geographical location of participating consumers as overwhelmingly in developed
countries; two-thirds were from the UK and North America with others in Australia and
Europe and only 4/63 from Asia or the Middle East [6]. This is supported by data from
the CRG case studies which reported similar patterns, with variations for the location of
the editorial bases (e.g. Canada, Germany) [20, 22, 23].
Barriers to consumer involvement identified by multiple organisations, including
Cochrane, were lack of time and resources, uncertainty over how to identify the “right”
consumers and concerns about possible negative impacts on scientific rigour [13].
Interestingly none of the case studies of CRGs focussed on barriers to involvement, al-
though they did note some enablers; this may be a reflection of a local track record in
overcoming such barriers.
Discussion
Summary of findings
The studies we identified had publication dates ranging from 1999 to the present. Most
of the evidence identified by this review related to Cochrane, although some studies
identified and evaluated other organisations’ involvement. In some instances, these cov-
ered the impact of novel strategies such as post-publication forums open to the general
public.
Within Cochrane there were evaluations across the organisation as a whole and
within individual review groups (CRGs). Evaluations and reports on individual CRGs
related to only four of the CRGs, although many more CRGs were identified as having
considerable consumer involvement by collaboration-wide surveys and audits.
The great majority of organisational level evidence related to Cochrane; however only
a minority of the individual reviews where an identified publication documented or
evaluated the impact of consumer involvement, related to Cochrane reviews. This may
of course reflect the fact that consumer involvement in Cochrane reviews is less novel,
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more routine and less likely to be identified as something “different enough” to be
worthy of a separate publication.
It was noteworthy that many of the identified case studies of individual reviews expli-
citly reported that consumer involvement led to changes in the review. It was therefore
easier to be confident that tangible impacts of consumer involvement occurred than
was the case with CRG or organisational level appraisals. This presentation of audit
trails of consumer input and the subsequent changes to reviews was documented expli-
citly by only one CRG study, [39] and by none of the organisational studies. Given that
these linkages were possible in all the reviews with substantive involvement, it would
be worth considering methods for reporting consumer input, at a structural level, in fu-
ture analyses.
Emerging themes
Although Cochrane is an international organisation and its reviews are increasingly
available in multiple languages, the focus of the identified research revealed overwhelm-
ingly Anglophone involvement and heavy concentration of consumer involvement in high
income countries. There was limited representation in published studies from low and
middle-income countries and countries where English is not a main language, with only
two studies focused on countries outside these categories (Germany and China) [9, 23].
One theme, which emerged from the analysis, is the increasing level of consumer in-
volvement in terms of the number of CRGs which routinely involve consumers in some
way in some or all of their reviews. Consumers are identified as contributing through-
out the research cycle, from priority setting; outcomes identification; commenting on
protocols reviews and plain language summaries; helping to disseminate knowledge;
and playing important roles within Review Group teams. However the involvement of
consumers often remains focused on providing input as consumer referees to reviews
or protocols and in assisting with the provision of plain language summaries. Involve-
ment of consumers in other more “upstream” activities such as prioritisation of topics
and outcome identification does not appear to show the same pattern of increasing
activity. In general there is evidence of inconsistency across the Cochrane network, in
terms of commitment to involvement, resources directed at involvement, and the var-
iety of different approaches taken.
Some individual Review Groups are well-represented in the literature revealing a
commitment both to involving consumers and to publishing the results of their work
(for example the Cochrane Muscular-Skeletal Group and the Cochrane Pregnancy and
Childbirth Group) [15, 20, 22, 39–42]. However, in general, there is a scarcity of infor-
mation about the extent and nature of consumer involvement in Review Groups and a
rarity of audit of involvement processes such that the impact of activity is unrecorded
in published literature.
A range of perceived barriers to effective involvement across both Cochrane and
other organisations are identified in the literature. These include a lack of resources,
guidance, language and the difficulty of recruiting suitable consumers. A clear range
of benefits from the involvement process are also identified including the use of
consumer-oriented and more relevant outcomes, changes in language, informing of
methodology and adding “depth” to the review. Whilst these perceived barriers and
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benefits are subjectively identified there is a shortage of objective evidence about
what works.
A particularly notable finding was that, at an organisational level, consumers them-
selves are often uncertain about the value of their contributions; editors and authors
appear to be more confident in this than those who are providing the consumer input
[6, 10]. This finding did not appear to be reflected in some of the reports from CRGs
and external organisations with high levels of commitment to consumer involvement
such as the Pregnancy and Childbirth CRG [15, 38–42]. It may be that improved com-
munication between consumers and the wider review team may make the impact of
their involvement clearer to consumers.
One theme which did clearly emerge from the studies of individual CRG processes
was that the level of benefit derived from consumer involvement was often propor-
tional to the level of investment of time and resources in obtaining and facilitating that
involvement. Structures and processes which were designed to support meaningful in-
put from consumers resulted in more engaged consumers and, ultimately, higher value
consumer contributions [6, 15].
Limitations of this review
This work does not represent a full systematic review of the literature. Although we
were able to have two authors independently screen the identified records from the da-
tabases (while blind to each other’s decisions), only one author assessed the abstracts
from the Cochrane Colloquia. We were unable to obtain two records despite an inter-
national inter-library loan request. Both of these were in German and may have served
to partially correct for the focus of the identified literature on involvement from Eng-
lish speaking countries. We were also unable to conduct a useful quality assessment of
the included studies as they represented a diversity of study designs and approaches;
many were also reported in abstract form only.
Limitations of the included studies
Almost all of the included studies were case studies, case series or reports of surveys or
audits. Only one adopted a comparative design and this took the form of a historical
control. Many of the studies did not attempt to assess the impact of particular types of
involvement and most of those which did supplied little or no evidence to support the
assertions of impact. Although attempts to audit and describe processes have value they
do not allow us to infer that reported outcomes are a consequence of these processes.
Conclusions
This scoping exercise has identified evidence of highly variable levels and types of con-
sumer involvement within and beyond Cochrane, but limited evidence for the impact
of most methods and levels of involving people. Promising initiatives exist and where
there is evidence of impact at the level of individual reviews and review groups it sup-
ports the need for properly resourced and supported processes in order to derive the
greatest benefit from the lived experiences of consumers who are willing to be involved.
Further, more rigorous evaluations are needed in order to determine the optimum
approach to achieving this.
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Recommendations for further research and practice
Whilst there are considerable difficulties in conducting controlled studies in this field it
would not be impossible to design a study which adopted a more rigorous approach to
evaluating which models of organisational consumer involvement have greatest impact
on the quality and relevance of the output. Different approaches to this might be
considered.
In the interim CRGs should be encouraged to record and publish their experiences of
consumer involvement, including any innovative processes they adopt. This would en-
able widespread and rapid adoption/exploration of processes which are found to be ef-
fective by particular groups. In particular CRGs should explore and document methods
of involving consumers throughout the research cycle including prioritisation, outcome
identification and dissemination to other consumers and consumer organisations.
Inclusivity and representativeness should be pursued by working towards ensuring
consumers reflect, as far as possible, the population as a whole in respect of gender,
age, ethnicity, disability, sexual orientation, socio-economic group, spoken language,
developed/developing world. This might be achieved through targeted recruitment pro-
grammes to improve representation of currently under-represented consumers from
low-income and non-English speaking countries.
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